Puerarin + tempo-modified beta-cyclodextrin
1 paper3 findings
- 1 lab in 1 country
- Funders: Key Research and Development Program of Zhejiang Province and 2 more
- Animals1
Outcomes
3Cellular senescence
downin mice1
1 study
Cellular senescence
downin mice1
Puerarin + tempo-modified beta-cyclodextrin decreases cellular senescence in mice.
“The P@TCD could mitigate the ROS accumulation, reduce DNA damage, promote cell cycle progression, and attenuate cellular senescence in the corneal epithelium”
Animalsin DEDcorneal epithelium
Antioxidant and anti-senescence supramolecular complexes for managing dry eye diseases
Bioactive materials13 Jun 2026
Corneal epithelial defects
downin mice1
1 study
Corneal epithelial defects
downin mice1
Puerarin + tempo-modified beta-cyclodextrin decreases corneal epithelial defects in mice.
“P@TCD demonstrated favorable therapeutic efficacy by reversing corneal epithelial defects”
Animalsin DED mouse modelscorneal epithelium
Antioxidant and anti-senescence supramolecular complexes for managing dry eye diseases
Bioactive materials13 Jun 2026
Tear break-up time
upin mice1
1 study
Tear break-up time
upin mice1
Puerarin + tempo-modified beta-cyclodextrin improves tear break-up time in mice (> 5.3 s vs < 2.8 s).
“improving tear film stability with TBUT values of more than 5.3 s, compared to the DED models of less than 2.8 s”
Animalsin DED mouse modelstear film
Antioxidant and anti-senescence supramolecular complexes for managing dry eye diseases
Bioactive materials13 Jun 2026